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Abstract 
Osteoporosis is a common problem in menopause woman. The main cause is lack of 
estrogen hormone. Commonly, prevention therapy is by consuming high calcium milk, but it 
is not effective. Bali orange’s peel (Citrus maxima Merr.) is a waste material but known 
contains phytoestrogen according to previous study. Considering of this result, fortification 
of high calcium milk and Bali orange’s peel is expected to be an effective solution for 
osteoporosis in menopause woman. This research began with extraction of Bali orange’s 
peel (BPE) using ethanol 70% by maceration method. Ovariectomized Sprague Dawley female 
rats as the model of post menopausal woman were treated by BPE for 28 days. The doses of 
BPE was given to rats is 500 and 1000 mg/KgBW combined with high calcium milk. Bone 
density was determined using digital microradiography, the profile showed the increase of 
bone density in group that treated with combination of BPE 1000 mg/Kg BW and high 
calcium milk compare to control and given only milk groups. Docking molecular showed that 
BPE’s active compound which are hesperidin and naringin have interaction with estrogen 
receptor α and β. Docking score of naringin with ER α and β are -19.97; -18.99 respectively. 
Meanwhile the docking score of hesperidin with ER α and β are -19.98; +49.92 respectively. 
Overall, the result of this research showed that fortification of BPE with high calcium milk 
has good prospect to develop as effective therapy of osteoporosis. 
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INTRODUCTION 
 
Osteoporosis is a disease that 
characterized by reduction in bone tissue mass 
per unit volume that effect thinner and fragile 
bone and less number of calcium contain 
(Liliana, 2000). The report from WHO says that 
in Asia, fracture caused by osteoporosis will 
increase from 84.000 cases in 1984 to 6.26 
million cases in 2050. Almost 71% of all cases 
happen in the developing countries (Sankraan, 
2000). One of two women in the world has a 
risk to have osteoporosis syndrome. The high 
incidence of osteoporosis in women cause this 
condition becomes a major health problem in 
society.  
Women at menopause state have 
higher risk to osteoporosis. Menopause is 
natural process that will be experienced by 
every woman. In this state, the function of 
ovaries to produce estrogen hormone will 
decrease. Resulting in a variety of physiological 
change include osteoporosis (Kenny, et al., 
2000). Decrease of estrogen production will be 
followed by increase calcium lost in woman 
body (Perry and O’Hanlan, 2003). Estrogen 
regulates OPG (Osteoprotegerin) that have a 
role in differentiation of macrophage to 
osteoclast which is affect in calcium 
metabolism pathway.  
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Regulation of osteoclastogenesis by OPG 
is to inhibit interaction between RANKL 
(Receptor Activated NF-κB Ligand) and its 
receptor that resulting decrease number of 
osteoclast formation (Sculi, et al., 2000). 
Nowadays, osteoporosis treatment for 
post-menopausal woman is consumption of 
high calcium milk and calcium supplement. By 
this treatment, the deficiency of calcium is 
decrease but osteoporosis still can occur 
(Noordin, 2009). Data from nutrition survey 
says that 30-40% of post-menopausal women in 
Indonesia consume high calcium milk, but still 
can be found high prevalence of osteoporosis 
case in Indonesia (Arifin, 2010). This shows 
that therapy has not been effective by milk 
consumption. 
Osteoporosis is not just caused by lack of 
calcium intake but also due to a decrease in 
estrogen production. One of therapy to prevent 
estrogen deficiency is the substitution of natural 
compounds that relatively safe in the form of 
phytoestrogens. Phytoestrogens are 
nonsteroidal chemical compounds in plants that 
have estrogenic activity (Yildiz, 2005). Bali 
orange’s peel (Citrus maxima) or BPE contain 
flavonoid naringin and hesperidin which has 
been proven as phytoestrogen (Choi, et al., 
2007). The estrogenic effects of BPE are 
increase bone density, modulate cholesterol 
blood profile, increased breast cell proliferation 
and increased uterine weight (CCRC 
unpublished data, 2011). High calcium milk 
was commonly used as osteoporosis therapy. 
Therefore, we did fortification using high 
calcium milk and BPE. Fortification is the 
addition of nutrients obtained or intentionally 
added from outside and not from the original 
food (BPOM, 2003). 
As the initial study was to know 
estrogenic effect of BPE, we did molecular 
docking to identify the interaction between 
estrogen receptor with phytoestrogen that 
contained in BPE. The results from this method 
become the basic for in vivo study to determine 
the effects of combination of high calcium milk 
and BPE in ovariectomized rat Sprague Dawley 
strains. The results of this research can be the 
basis for the formulation of high-calcium milk 
with BPE and also solve the problem of 
osteoporosis in postmenopausal women. 
 
MATERIALS AND METHODS 
 
Plant and extract preparation 
Citrus maximas were collected from 
Jedigan, Trirenggo, Bantul. The sample was 
determined at the laboratory of plant taxonomy, 
Faculty of Biology, Universitas Gadjah Mada, 
Yogyakarta, Indonesia. Citrus maxima peels 
were collected, dried using oven under 
temperature 40
o
C, then made into powder using 
grinder, and extracted with 70% ethanol using 
maceration method. Macerate was concentrated 
using a rotary evaporator to obtain viscous 
extract (BPE).  
 
Animals Preparation 
Thirty eight female Sprague-Dawley 
rats, age 40-50 days were obtained from UPHP 
(Unit Pengembangan Hewan Percobaan) 
Universitas Gadjah Mada, Yogyakarta, 
Indonesia. The animals were grouped and 
housed in cages at temperature and humidity-
controlled room (25-32
o
C and 98% relative 
humidity) and given free access to food and 
water. The animals were given time to adapt 
with laboratory condition for 10 days. 
 
Bone density analysis 
The femoral bones were carefully 
removed at necropsy. The right femur of each 
rat was used for qualitative and quantitative 
analysis. Qualitative and quantitative analysis 
were done by measuring bone density using 
microradiography digital in Imaging 
Laboratory, Faculty of Science, Universitas 
Gadjah Mada. 
 
Molecular Docking 
The program that we used for molecular 
docking was PLANTS 1.1. Estradiol was used 
as native ligand to compare the ligand bond 
strength. Test compounds or test ligands were 
naringin, hesperidin. Then molecular docking 
was performed between 17β-estradiol (native 
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ligand), naringin, hesperidin to Estrogen 
Receptor α and Estrogen Receptor β.  Scoring 
was done for the docking results. 
 
Data Analysis 
The compound or test ligand that has 
lowest score in molecular docking showed the 
strongest affinity to receptor. Bone density data 
were analyzed by Excel MS Office 2007 and 
SPSS 17 One way ANOVA was used to assess 
concentration (p<0.05) then post-hoc 
comparisons were made using Tukey 
significant different test. 
 
RESULT AND DISCUSSION 
 
Identification of BPE Flavonoid Content 
Using Thin Layer Chromatography 
According to Choi, et al. (2007) Bali 
orange’s peel (BPE) contain flavonoid such as 
naringenin, hesperidin, rutin, tangeretin, and 
nobiletin. To identify flavonoid content of BPE, 
we used thin layer chromatography (TLC). 
From TLC assay qualitative type of flavonoid 
contained in BPE can be seen (Fig. 2). 
Reference compound that we use is rutin, 
naringenin, and hesperidin. 
Some information that we can see 
through TLC profile are polarity and type of 
compound in BPE. Polarity of compound can 
be determined using Retention factor (Rf) 
whereas the identification of compound through 
colour change after spray reaction using AlCl3 
under UV 366 nm.  
The main characteristic of flavonoid 
compound, according to Wagner, et al. (2000) 
is fluorescence in green-yellow color under UV 
366 nm. So that, it can be seen that BPE contain 
flavonoid compound. Based on TLC profile 
obtained can be conclude that the flavonoid 
compounds that have been identified in BPE are 
rutin, naringenin, and hesperidin. It showed by 
the similarity of hRf value from each spotand 
the color of fluorescence after observed under 
UV 366 nm. 
 
 
 
  
 : Shame Ovariectomized  : Necropsy  
 : Ovariectomized  : Treatment 
 : Recovery   
 
Figure 1. Experimental design. The rats divided into seven groups of 5-6. The groups were baseline non 
ovariectomy (baseline OVX), baseline ovariectomy (baseline OVX), solven control (OVX+CMC-Na), 
positive control (OVX+Estradiol), control milk (OVX+High calcium milk), Milk+BPE treatment dose 500 
mg/kg BW (OVX+BPE500) and treatment with Milk+BPE dose 1000 mg/kgBW (OVX+BPE1000). 
Baseline groups were sacrificed at 70 days old, while other groups were start given treatment. 
Treatments were given for 28 days. At the end of experimental period, animals were sacrificed, and then 
femoral bones were collected. 
Groups 
Rat’s age 
 50 
days 
  
70 
days 
  
98 
days 
1. Baseline NOVX          
 
 
 
 
Analysis of 
bone density 
profile 
 
2. Base line OVX        
3.Negative control OVX 
not treated 
       
4. Positive control  OVX + 
    Estradiol 
       
5. Control OVX+milk        
6.Milk+BPE treatment 
   OVX + 500 mg/kgBW 
       
7.Milk+BPE treatmekgnt 
   OVX + 1000 mg/kgBW 
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Figure 2. TLC profile of BPE after elution. Using silica gel GF 254 as stationary phase and mobile phase ethyl 
acetate: methanol: formic acid (95 : 5 : 0,5% v/v/v). (1) BPE; (2) Rutin; (3) Naringenin ; (4) Hesperidin. 
There are some spots of BPE that have the same hRf with reference compound but in different colour 
intensities. From TLC profile known that hesperidin is one of major compound of BPE. After spray 
reaction and observed under UV 366 nm, some spots which fluorescence in green-yellow color indicating 
flavonoid compound. 
 
 
Effectiveness of the addition of BPE on High Calcium Milk to Increase Bone Density 
Ovariectomized Female Rats 
 
Figure 3. Bone density profile from each group after 28 days treatment. Data show quantitative bone 
density. Value indicates mean from each group + standard error bar. Bone density profile from each 
treatment groups did not differ significantly (p>0.05) by ANOVA followed by Tuckey test. However, 
there is a tendency to increase the bone density of treatment of milk and BPE at dose 1000 mg/kg BW 
when compared with the untreated control and control milk group. 
 
 
 
Female rats were ovariectomized to 
obtain the model of post-menopausal woman 
condition. After ovariectomy, test animal will 
experience estrogen deficiency and not receive 
estrogen intake apart from BPE or estradiol for 
the positive control. This treatment was done in 
order to determine the estrogenic effect of BPE 
in increasing bone density (Fig. 3) 
Bone density at baseline OVX group 
decreased compared to baseline non-OVX 
indicating that ovariectomy surgery has 
successfully carried out in this study. Based on 
statistic test, it is found that the bone density 
profile of the treatment groups was not 
significantly different from each group. 
However, from graphic above we can see the 
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trend of increasing bone density of the group 
treated with a combination of milk and BPE at 
higher doses compared with the control milk. 
This indicates that the BPE potentially improve 
the effectiveness of milk in increasing bone 
density.  
The results showed that administration of 
a combination of high calcium milk with EJB in 
general has the potency to increase bone density 
on ovariectomized female rats. In the state of 
estrogen deficiency, calcium in the body can 
not improve bone density optimally. This is due 
to the imbalance of osteoblast and osteoclast 
activity. Deficiency of estrogen makes the 
activity of osteoclast increase. By the addition 
of BPE as estrogenic substances source can 
optimize the maintanance of bone density. This 
mechanism is mediated by inhibition of 
osteoclast activity through osteoprotegerin 
(OPG), which is a decoy receptor in the 
activation of osteoclasts. 
 
Interaction of Estrogen Receptor α 
and β to Flavonoid Content of BPE 
by Molecular Docking 
Docking is done to predict the ability of 
the active compounds (ligands) to interact with 
estrogen receptors (ERα and ERβ). Estrogen is 
an intracellular receptor that is one of the 
regulators on calcium metabolism. If activated 
by ligands, estrogen receptor will affects 
osteoclast differentiation via formation of 
osteoprotegerin (OPG). 
Native ligand used is 17β-estradiol to 
compare the ability of the bond or affinity of 
naringin and hesperidin with estrogen receptor. 
The parameters used are docking score that 
represents the energy required to bind the 
receptor. The lower scores obtained by docking 
the stronger bonding compounds with ligands. 
Score docking compounds on estrogen receptor 
ligand can be seen in Table 1. 
 
Tabel 1. Docking score in ERα dan ERβ 
Ligan 
Score 
ERα ERβ 
Estrogen (17β-estradiol) -20.00 -20.00 
Naringin -19.97 -18.99 
Hesperidin -19.98 +49.12 
 
 
 
 
 
 
 
 
 
 
(A)                                           (B)                                            (C) 
Figure 4.  Docking visualization using MOE application. Describe interaction between ligand and ERβ. Ligand 
(A) 17β-estradiol; (B) naringenin; (C) hesperidin showed in red image interact with receptor in the same 
active site. Reported that the bonds between the ligand and the receptor are hydrogen bond symbolized 
by the pink and green color through the hydrophobic bond. 
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Docking results showed that naringin 
and hesperidin have a similar affinity to 17β-
estradiol against Erα. This is indicating with 
similar of docking score to ERα. However, the 
docking results showed that only naringin Erβ 
having docking score similar to 17β-estradiol, 
while docking score hesperidin has a much 
higher. Thus, only naringin which has affinity 
with Erβ, showed by docking score that not 
significantly different with native ligand. 
Docking score differences on hesperidin 
showed selectivity in estrogen receptor 
activation. This makes hesperidin to develop as 
potential selective estrogenic substance. Strong 
activation of estrogen receptor β will trigger 
uterine cancer in women. The docking results 
corroborate previous research that says that the 
flavonoid compound is estrogenic. 
Based on this study, the combination of 
BPE and high calcium milk could potentially 
increase bone density ovariectomized female 
rats because of the phytoestrogens are able to 
bind to Estrogen Response Element (ERE) as 
evidenced by molecular docking. 
 
ACKNOWLEDGEMENT 
 
We acknowledge Directorate General of 
Higher Education, Ministry of Education and 
Culture, Republic of Indonesia who has funded 
this research in 2012 through Student Creativity 
Program. 
 
REFERENCES 
 
Arifin, Z., Hestiantoro, A., and Baziad, A., 2010, 
Pemberian Susu yang Difortifikasi 
Kalsium Kadar Tinggi dan Vitamin D 
dalam Memperbaiki Turn Over Tulang 
Perempuan Pascamenopause, Laporan 
Penelitian, Jakarta: Departemen 
Obstetri dan Ginekologi Fakultas 
Kedokteran Universitas 
Indonesia/RumahSakit Dr. Cipto 
Mangunkusumo. 
Badan Pengawasan Obat dan Makanan, 2003, 
Pedoman Penilaian Label Pangan, 
Jakarta: BPOM. 
 
Benassayag, C., Perrot-Applanat, M., and Ferre, 
F., 2002, Phytoestrogen as 
Modulators of Steroid Action in 
Target Cells, J. Chromatogr. B, 777(1-
2), 233-248.  
CCRC, 2011, Efek Estrogenik Ekstrak Etanolik 
Kulit Buah Jeruk Bali (Citrus maxima 
Merr.): Tinjauan Terhadap Bobot Uterus, 
Perkembangan Kelenjar Payudara, dan 
Ekspresi c-Myc pada Tikus Sprague 
Dawley Betina Terovariektomi, 
Unpublished data. 
Choi, S.Y., Ko, H.C., Ko, S.Y., Hwang, J.H., 
Park, J.G., Kang, S.H., et al., 2007, 
Correlation between Flavonoid 
Content and the NO Production 
Inhibitory Activity of Peel Extracts 
from Various Citrus Fruits, Biol. 
Pharm. Bul., 30(4), 772-778.  
Cornwell, T., Cohick, W. and Raskin, I., 2004, 
Dietary Phytoestrogens and Health, 
Phytochemistry, 65(8), 995-1016. 
Ikawati, Z., 2008, Pengantar Farmakologi 
Molekuler, Yogyakarta: Gama Press. 
Kenny, A.M., Prestwood, K.M., Pilbeam, C.C. 
and Raisz, L.G., 2000, The Short 
Term Effects of Tamoxifen on Bone 
Turnover in Older Women, J. Clin. 
Endocrinol. Metab., 80(11), 3287-3291. 
Liliana, 2000, Metabolisme Kalsium dan 
Pencegahan Osteoporosis. di dalam eber 
Papyrus, Fakultas Kedokteran 
Universitas Tarumanegara, Jakarta. 
Muirden, K.D., 1994, Osteoporosis Kumpulan 
Naskah WHO-COPCORD-IRA Post 
Graduate Course, Jakarta: WHO-
COPCORD-IRA, 1 – 3. 
Nadendla, R.R., 2004, Molecular Modeling: A 
Powerful Tool for Drug Design and 
Molecular Docking, Resonance, 9(5), 
51-60.  
Nordin, B.E., 2009, The Effect of Calcium 
Suplementation on Bone Loss in 32 
Controlled Trials in Postmenopausal 
Women, Osteoporosis Int., 20(12), 
2135-2143.  
Pacifici, R., 2006, Estrogen, Cytokines, and 
Pathogenesis of Postmenopausal 
Osteoporosis, J. Bone Miner. Res., 
11(8), 1043-1051.  
Perry, S. and O’Hanlan, K.A., 2003, Natural 
Menopause, New York: Addison-
Wesley Publishing Company. 
 
Dianigati, et al., 2015 
Indones. J. Cancer Chemoprevent., 6(2), 42-48  
 
48 
 
Sankaran, B., 2000, Osteoporosis: Clinical, 
Radiological, Histological, Assesment and 
an Experimental Study, New Delhi: 
South East Asia Regional Office of the 
World Health Organisation. 
Wagner, H., Bladt, S., and Zgainski, E.M., 1984, 
Plant Drug Analysis A Thin Layer 
Chromatography Atlas, Berlin: Springer 
Verlag. 
Whitten, P.L. and Patisaul, H.B, 2001, Cross-
Species and Interassay Comparisons 
of Phytoestrogen Action, Environ. 
Health  Perspect., 109(Suppl. 1),  5-20. 
Yildiz, F., 2005, Phytoestrogens in Functional 
Foods, Boca Raton: CRC Press. 
 
 
